BURLINGTON, ON,
March 4, 2014 /CNW/ - EcoSynthetix
Inc. (TSX:ECO) ("EcoSynthetix" or the "Company"), a renewable
chemicals company that produces a family of commercially proven
bio-based products, today announced its financial results for the
three and twelve months ended December 31,
2013. Financial references are in U.S. dollars unless
otherwise indicated.
Fourth Quarter and Fiscal 2013
Highlights
- Net sales increased 14% to $22.2
million for fiscal 2013 compared to $19.6 million in fiscal 2012, while sales in the
three months ended December 31, 2013
were $5.2 million compared to
$5.9 million in the same period last
year
- Won five new customers during calendar 2013 and one new
customer subsequent to the end of the period
- Two new binder grades targeting the paper and paperboard market
have driven a significant increase in mill trial activity with
multiple evaluations underway
- Commercial strategy for sustainable building products advancing
with North American and European manufacturers with qualification
trials underway.
"During 2013, we continued to make progress
across multiple facets of the business. We grew sales by 14%, we
introduced new high performance grades of our EcoSphere biolatex
binders into the paper and paperboard market and we made
significant progress on the commercialization of our proprietary
bio-based binders in the wood composites and insulation markets,"
said John van Leeuwen, Chief
Executive Officer of EcoSynthetix. "While the paper market remains
challenging given the pressure on butadiene prices, the positive
feedback on the new grades has driven a significant increase in
mill trial activity. Our focus remains one of execution,
specifically growing sales in the paper and paperboard market and
building our product development capabilities to expand into new
markets, like building materials."
Financial Summary
Net Sales
Net sales for the three months ended
December 31, 2013 (Q4 2013) were
$5.2 million compared to $5.9 million for the three month period ended
December 31, 2012 (Q4 2012), a change
of $0.7 million. Sales increased
$0.9 million in North America compared to the fourth quarter
in 2012, principally due to higher volumes to existing customers.
This increase was offset by lower sales in Asia Pacific and EMEA of $1.0 million and $0.7
million respectively. Sales decreased in EMEA primarily due
to the closure of a customer's coated paper production line in the
region during the quarter.
Net sales for fiscal 2013 were $22.2 million compared to $19.6 million in the prior period, an increase of
$2.6 million. The 14% increase in net
sales was primarily due to higher sales in North America, Latin
America and Europe of
$4.4 million, $0.5 million and $0.2
million, respectively, partially offset by lower sales in
Asia Pacific of $2.4 million. Sales decreased in Asia Pacific due to the competitive pressures
resulting from unfavorable market dynamics caused by the
over-supply of butadiene and the related drop in butadiene and SB
latex prices.
Gross Profit
Gross profit was $0.9
million for Q4 2013, or 17.4% of revenue, compared to
$1.2 million, or 20.1% of revenue, in
Q4 2012. Gross profit adjusted for non-cash items as a percentage
of sales was 22.9% for Q4 2013 compared with 25.2% in the same
period last year. The change was principally due to lower sales
volume and higher corn starch costs.
For fiscal 2013, gross profit was $3.6 million, or 16.2% of revenue, compared to
$3.9 million, or 19.7% of revenue in
the prior period. Gross profit adjusted for non-cash items as a
percentage of sales was 21.3% for fiscal 2013 compared with 24.9%
last year. The change in gross profit during fiscal 2013 was
primarily due to higher corn starch prices and lower selling prices
partially offset by higher sales volume.
Selling, General and Administrative
(Excludes share-based compensation, depreciation and
amortization and foreign exchange loss or gain)
Selling, general and administrative (SG&A)
costs were unchanged at $2.9 million
for both Q4 2013 and Q4 2012. For fiscal 2013, SG&A costs were
$11.6 million compared to
$10.2 million in 2012. The change is
primarily due to higher salaries & benefits associated with a
20% increase in headcount compared to fiscal 2012.
Research and Development
(Excludes share-based compensation, depreciation and
amortization and foreign exchange loss or gain)
Research and development (R&D) expenses were
unchanged at $1.5 million in both Q4
2013 and Q4 2012. For fiscal 2013, R&D costs were $5.5 million compared to $4.4 million in 2012. R&D is a key focus of
EcoSynthetix to enhance its bio-based material product portfolio
and expand into new applications and markets. The increase in
R&D expenses in 2013 reflects the Company's ongoing investment
in product development and innovation.
Adjusted EBITDA1
Adjusted EBITDA for the quarter was ($3.3) million, compared to ($3.0) million in Q4 2012, a decrease of
$0.3 million or 10%. The
decrease was primarily due to lower gross profit. For fiscal
2013, adjusted EBITDA was ($12.4)
million, compared to ($9.7)
million in the prior period, a decrease of $2.7 million or 28%. The decrease was
primarily due to higher operating expenses and lower gross
profit.
Net Loss
Net loss in Q4 2013 was $3.6 million, or $0.07 per common share (basic and fully diluted),
compared to a net loss of $3.4
million, or $0.06 per share
(basic and fully diluted), in Q4 2012. For fiscal 2013, net loss
was $14.8 million, or $0.26 per common share (basic and fully diluted),
compared to $11.4 million, or
$0.21 per common share (basic and
fully diluted), in the prior period. The increase in net loss
during fiscal 2013 is primarily due to increased operating expenses
and lower gross profit.
Liquidity
Working capital was $87.3
million at December 31, 2013,
compared to working capital of $100.2
million at December 31, 2012.
The change in working capital was principally due to cash utilized
in operating activities.
Notice of Conference Call
EcoSynthetix will host a conference call on
Wednesday, March 5, 2014, at
8:30 AM ET to discuss its financial
results. John van Leeuwen,
CEO, and Robert Haire, CFO, will
co-chair the call. All interested parties can join the call by
dialling (647) 427-7450 or (888) 231-8191. Please dial in 15
minutes prior to the call to secure a line. A live audio webcast of
the conference call will also be available at www.ecosynthetix.com.
The presentation will be accompanied by slides, which will be
available via the webcast link. Please connect at least 15 minutes
prior to the conference call to ensure adequate time for any
software download that may be required to join the webcast.
1Non-IFRS Financial
Measures
This press release makes reference to certain
non-IFRS measures. These non-IFRS measures are not recognized
measures under IFRS, do not have a standardized meaning prescribed
by IFRS and are therefore unlikely to be comparable to similar
measures presented by other companies. Rather, these measures are
provided as additional information to complement those IFRS
measures by providing a further understanding of results of
operations of EcoSynthetix from management's perspective.
Accordingly, they should not be considered in isolation nor as a
substitute for analysis of the financial information of
EcoSynthetix reported under IFRS. The Company uses non-IFRS
measures such as Adjusted EBITDA to provide investors with a
supplemental measure of operating performance and thus highlight
trends in its core business that may not otherwise be apparent when
relying solely on IFRS financial measures. Management also believes
that securities analysts, investors and other interested parties
frequently use non-IFRS measures in the evaluation of issuers.
Management also uses non-IFRS measures in order to facilitate
operating performance comparisons from period to period, prepare
annual operating budgets and assess the Company's ability to meet
its capital expenditure and working capital requirements.
Adjusted EBITDA is not a measure recognized
under IFRS and does not have a standardized meaning prescribed by
IFRS. The Company presents Adjusted EBITDA because the Company
believes it facilitates investors' use of operating performance
comparisons from period to period and company to company by backing
out potential differences caused by variations in capital
structures (affecting relative interest expense), the book
amortization of intangibles (affecting relative amortization
expense) and the age and book value of property and equipment
(affecting relative depreciation expense). The Company also
presents Adjusted EBITDA because it believes it is frequently used
by securities analysts, investors and other interested parties as a
measure of financial performance. Adjusted EBITDA as presented
herein is not a recognized measure under IFRS and should not be
considered as an alternative to operating income or net income as a
measure of operating results or an alternative to cash flows as a
measure of liquidity. Adjusted EBITDA is defined as consolidated
net income (loss) before interest, income taxes, depreciation,
amortization and other non-cash expenses deducted in determining
consolidated net income (loss) before interest, income taxes,
depreciation, amortization, other non-cash expenses and charges
which include the movement in the unrealized gains and losses on
the Company's redeemable preferred shares and warrants classified
as financial liabilities prior to the initial public offering and
share based compensation expense.
The following table reconciles net loss to
Adjusted EBITDA for Q4 2013 and Q4 2012:
|
|
|
|
December 31,
2013 |
December 31,
2012 |
Net loss |
(3,636,080) |
(3,394,357) |
Depreciation and amortization |
596,824 |
384,769 |
Share-based compensation |
(137,754) |
145,000 |
Interest income |
(87,611) |
(85,776) |
Adjusted EBITDA (1) |
(3,264,621) |
(2,950,364) |
About EcoSynthetix Inc.
(www.ecosynthetix.com)
EcoSynthetix Inc. is a renewable chemicals company specializing in
bio-based products that can be used as inputs in industrial
manufacturing for a wide range of consumer products. The Company's
products offer a reduced carbon footprint and are marketed
primarily on the basis of lower cost, stable pricing and equal or
superior performance. EcoSynthetix's lead product,
EcoSphere® biolatex® binders, is used
commercially by a number of the global top 20 manufacturers in the
coated paper and paperboard industry.
Forward Looking Statements
Certain statements in this Press Release constitute "forward
looking" statements that involve known and unknown risks,
uncertainties and other factors which may cause the actual results,
performance, objectives or achievements of the Company, or industry
results, to be materially different from any future results,
performance, objectives or achievements expressed or implied by
such forward looking statements. These statements reflect our
current views regarding future events and operating performance and
are based on information currently available to us, and speak only
as of the date of this Press Release. These forward looking
statements involve a number of risks, uncertainties and assumptions
and should not be read as guarantees of future performance or
results, and will not necessarily be accurate indications of
whether or not such performance or results will be achieved. Those
assumptions and risks include, but are not limited to, the fact
that our results of operations and business outlook are subject to
significant risk, volatility and uncertainty. Many factors could
cause our actual results, performance or achievements to be
materially different from any future results, performance or
achievements that may be expressed or implied by such forward
looking statements, including the factors identified in the "Risk
Factors" section of the Company's Annual Information Form dated
March 28, 2013. Should one or more of
these risks or uncertainties materialize, or should assumptions
underlying the forward looking statements prove incorrect, actual
results may vary materially from those described in this Press
Release as intended, planned, anticipated, believed, estimated or
expected. Unless required by applicable securities law, we do not
intend and do not assume any obligation to update these forward
looking statements.
EcoSynthetix Inc. |
|
|
|
Consolidated Balance Sheets |
|
|
|
At December 31 |
|
|
|
(Expressed in US dollars), unaudited |
|
|
|
|
|
|
|
|
2013 |
|
2012 |
|
|
|
|
Assets |
|
|
|
Current assets |
|
|
|
Cash |
80,506,957 |
|
93,260,296 |
Accounts receivable |
3,691,791 |
|
4,309,355 |
Inventory |
6,470,410 |
|
6,822,619 |
Government grants receivable |
261,648 |
|
184,118 |
Prepaid expenses |
276,856 |
|
154,492 |
|
91,207,662 |
|
104,730,880 |
Non-current assets |
|
|
|
Intangible assets |
124,009 |
|
163,501 |
Property, plant and equipment |
12,775,188 |
|
13,174,416 |
Total assets |
104,106,859 |
|
118,068,797 |
|
|
|
|
Liabilities |
|
|
|
|
|
|
|
Current liabilities |
|
|
|
Accounts payable and accrued
liabilities |
3,947,385 |
|
4,282,296 |
Deferred government grant |
- |
|
226,920 |
Total liabilities |
3,947,385 |
|
4,509,216 |
|
|
|
|
Shareholders' Equity |
|
|
|
Common shares |
492,600,022 |
|
492,065,820 |
Contributed surplus |
7,661,849 |
|
6,831,354 |
Accumulated deficit |
(400,102,397) |
|
(385,337,593) |
Total shareholders' equity |
100,159,474 |
|
113,559,581 |
|
|
|
|
Total liabilities and shareholders'
equity |
104,106,859 |
|
118,068,797 |
EcoSynthetix Inc. |
|
|
|
|
|
|
|
|
Consolidated
Statements of Operations and Comprehensive Loss |
|
|
|
|
|
|
|
(Expressed in US dollars), unaudited |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Three months
ended December 31, |
|
|
Fiscal
year-ended December 31, |
|
2013 |
|
2012 |
|
|
2013 |
|
2012 |
|
|
|
|
|
|
|
|
|
Net sales |
5,159,069 |
|
5,923,661 |
|
|
22,229,846 |
|
19,552,345 |
Cost of sales |
4,263,475 |
|
4,730,908 |
|
|
18,620,771 |
|
15,694,487 |
Gross profit on sales |
895,594 |
|
1,192,753 |
|
|
3,609,075 |
|
3,857,858 |
|
|
|
|
|
|
|
|
|
Expenses |
|
|
|
|
|
|
|
|
Selling, general and administrative |
2,741,474 |
|
3,153,970 |
|
|
12,916,606 |
|
11,266,518 |
Research and development |
1,877,811 |
|
1,518,916 |
|
|
5,814,787 |
|
4,382,854 |
|
4,619,285 |
|
4,672,886 |
|
|
18,731,393 |
|
15,649,372 |
Loss from operations |
(3,723,691) |
|
(3,480,133) |
|
|
(15,122,318) |
|
(11,791,514) |
|
|
|
|
|
|
|
|
|
Interest income |
87,611 |
|
85,776 |
|
|
357,514 |
|
360,779 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net loss and comprehensive loss |
(3,636,080) |
|
(3,394,357) |
|
|
(14,764,804) |
|
(11,430,735) |
|
|
|
|
|
|
|
|
|
Basic and diluted loss per common
share |
(0.07) |
|
(0.06) |
|
|
(0.26) |
|
(0.21) |
Weighted average number of
common shares outstanding |
55,802,382 |
|
55,297,736 |
|
|
56,113,610 |
|
55,288,432 |
EcoSynthetix Inc. |
|
|
|
|
|
|
|
|
Consolidated
Statements of Cash Flows |
|
|
|
|
|
|
|
|
(Expressed in US dollars),
unaudited |
|
|
|
|
|
|
|
|
|
Three months
ended December 31, |
|
|
Fiscal
year-ended December 31, |
|
2013 |
|
2012 |
|
|
2013 |
|
2012 |
Cash provided by (used in) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Operating activities |
|
|
|
|
|
|
|
|
Net loss |
(3,636,080) |
|
(3,394,357) |
|
|
(14,764,804) |
|
(11,430,735) |
Items not affecting cash |
|
|
|
|
|
|
|
|
|
Depreciation and amortization |
596,824 |
|
384,769 |
|
|
1,731,765 |
|
1,207,584 |
|
Share-based compensation |
(137,754) |
|
145,000 |
|
|
956,225 |
|
847,104 |
Changes in non-cash working
capital |
|
|
|
|
|
|
|
|
|
Accounts receivable |
149,210 |
|
156,416 |
|
|
617,564 |
|
(1,192,910) |
|
Inventory |
819,974 |
|
794,393 |
|
|
490,539 |
|
3,535,225 |
|
Government grants receivable |
(80,699) |
|
254,099 |
|
|
(77,530) |
|
455,567 |
|
Prepaid expenses |
77,185 |
|
59,892 |
|
|
(122,364) |
|
28,350 |
|
Accounts payable and accrued liabilities |
(1,066,391) |
|
642,413 |
|
|
123,088 |
|
(6,120) |
|
Deferred government assistance |
- |
|
(234,103) |
|
|
(226,920) |
|
(10,080) |
|
(3,277,731) |
|
(1,191,478) |
|
|
(11,272,437) |
|
(6,566,015) |
|
|
|
|
|
|
|
|
|
Investing activities |
|
|
|
|
|
|
|
|
Purchase of intangible
assets and property, plant and equipment |
(161,302) |
|
(403,264) |
|
|
(1,889,374) |
|
(5,748,063) |
|
|
|
|
|
|
|
|
|
Financing activities |
|
|
|
|
|
|
|
|
Repurchase of common shares |
- |
|
- |
|
|
- |
|
(521,729) |
Exercise of common share options |
7,887 |
|
3,614 |
|
|
283,844 |
|
145,398 |
Exercise of warrants |
29,329 |
|
- |
|
|
124,628 |
|
- |
Increase in government grant |
- |
|
237,000 |
|
|
- |
|
237,000 |
|
37,216 |
|
240,614 |
|
|
408,472 |
|
(139,331) |
|
|
|
|
|
|
|
|
|
Decrease in cash
during the period |
(3,401,817) |
|
(1,354,128) |
|
|
(12,753,339) |
|
(12,453,409) |
|
|
|
|
|
|
|
|
|
Cash - Beginning of
period |
83,908,774 |
|
94,614,424 |
|
|
93,260,296 |
|
105,713,705 |
Cash - End of period |
80,506,957 |
|
93,260,296 |
|
|
80,506,957 |
|
93,260,296 |
SOURCE EcoSynthetix Inc.